Ziel
Over the past two decades, the pharmaceutical industry has witnessed an exponential growth in approved covalent drugs. The majority of such drugs incorporate a chemical warhead, a mild electrophilic reactive functional group that forms covalent bonds in a reversible or irreversible manner with nucleophilic aminoacid residues. The aim of this proposal is to assess the viability of a new chemical warhead in the discovery of novel kinase inhibitors.
Wissenschaftliches Gebiet
Schlüsselbegriffe
Programm/Programme
- HORIZON.1.1 - European Research Council (ERC) Main Programme
Thema/Themen
Finanzierungsplan
HORIZON-ERC-POC - HORIZON ERC Proof of Concept GrantsGastgebende Einrichtung
FUNDACIO PRIVADA INSTITUT CATALA D'INVESTIGACIO QUIMICA
Netto-EU-Beitrag
€ 150 000,00
Adresse
AVENIDA PAISSOS CATALANS 16
43007 Tarragona
Spanien
43007 Tarragona
Spanien
Region
Este
Cataluña
Tarragona
Aktivitätstyp
Research Organisations
Links
Gesamtkosten
Keine Daten